Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-02-012415
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2074513z10-k405.htm 10-K405 567432
3 EXHIBIT 10.22 a2074513zex-10_22.htm EX-10.22 8427
4 EXHIBIT 10.23 a2074513zex-10_23.htm EX-10.23 18360
5 EXHIBIT 23.1 a2074513zex-23_1.htm EX-23.1 2487
6 G728911.JPG g728911.jpg GRAPHIC 61419
  Complete submission text file 0000912057-02-012415.txt   660036
Mailing Address 240 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 240 E GRAND AVE SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-29889 | Film No.: 02592714
SIC: 2834 Pharmaceutical Preparations